Central regions | Finance, business | Technology & innovation

HIV drug development under way, gets Skolkovo support

30 May '16
Viriom, a biomedical developer and asset of the ChemRar High Tech Center in Khimki outside Moscow, has been working on Russia’s first HIV solution which is expected to go beyond import substitution—an across-the-board goal the Russians have been pursuing in many sectors since the current crisis and western sanctions began—and offer “high potential for international commercialization.”

The new drug candidate’s safety, high efficacy and tolerance are said to have been proven during five rounds of phases 1 and 2 clinical trial testing. Phase 3 of clinical trials is currently under way in 18 AIDS prevention centers across Russia.

The Skolkovo Foundation, which is managing Russia’s most widely touted innovation hub just outside Moscow, earlier this year approved a new $2.2m grant for the next stage of the effort.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Latest News: Central regions
18 Jun '18 | Finance, business | Technology & innovation
8 Jun '18 | Technology & innovation | Finance, business
6 Jun '18 | Technology & innovation | Finance, business
4 Jun '18 | Finance, business | Technology & innovation
 

Feature stories

7 Jun '18
Russian scientists have come up with a new method of...
3 Apr '18
In regions most of European Russians will hardly ever...
21 Nov '17
Russian scientists have come up with what they say is...
Search (News archive - 21247)
Advertising
RB_Partners_Report
Advertising
gcvsymposium
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

18 Jun '18
BKS, a Russian company, and its partners are running...
15 Jun '18
Technology that comes from Krasnoyarsk in Siberia is...
14 Jun '18
Severstal, one of Russia’s largest mining and...

Most read stories from last week

18 Jun '18
BKS, a Russian company, and its partners are running...